Next Article in Journal
Strain-Induced Robust Exchange Bias Effect in Epitaxial La0.7Sr0.3MnO3/LaFeO3 Bilayers
Next Article in Special Issue
Addressing the Evolution of Cardenolide Formation in Iridoid-Synthesizing Plants: Site-Directed Mutagenesis of PRISEs (Progesterone-5β-Reductase/Iridoid Synthase-like Enzymes) of Plantago Species
Previous Article in Journal
The Discovery, Molecular Cloning, and Characterization of Dextransucrase LmDexA and Its Active Truncated Mutant from Leuconostoc mesenteroides NN710
Previous Article in Special Issue
Health-Related Composition and Bioactivity of an Agave Sap/Prickly Pear Juice Beverage
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 14
10.3390/molecules29143243
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of the Antioxidant and Anti-Inflammatory Activities and Acute Toxicity of Caco Seed (Chrysobalanus icaco L.) in Murine Models

by
Abel Arce-Ortiz
1,
Cristian Jiménez-Martínez
2,*,
Gabriel Alfonso Gutiérrez-Rebolledo
2,
Luis Jorge Corzo-Ríos
3,
Zendy Evelyn Olivo-Vidal
1,
Rosalva Mora-Escobedo
2,
Yair Cruz-Narváez
4 and
Xariss M. Sánchez-Chino
5,*
1
Departamento de Salud, El Colegio de la Frontera Sur Unidad Villahermosa, Carretera Federal Villahermosa-Reforma Km 15.5, Ra. Guineo Segunda Sección, C.P., Villahermosa 86280, Tabasco, Mexico
2
Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Unidad Profesional Adolfo López Mateos, Zacatenco, Av. Wilfrido Massieu Esq. Cda. Miguel Stampa S/N, Alcaldía Gustavo A. Madero, Mexico City 07738, Mexico
3
Unidad Profesional Interdisciplinaria de Biotecnología, Instituto Politécnico Nacional, Av. Acueducto, La Laguna Ticomán, Alcaldía Gustavo A. Madero, Mexico City 07340, Mexico
4
Laboratorio de Posgrado e Investigación de Operaciones Unitarias, Escuela Superior de Ingeniería Química e Industrias Extractivas, Instituto Politécnico Nacional, Zacatenco, Unidad Profesional Adolfo López Mateos, Col. Lindavista, Mexico City 07738, Mexico
5
Catedra-CONAHCYT, Departamento de Salud, El Colegio de la Frontera Sur-Villahermosa, Carretera Federal Villahermosa-Reforma Km 15.5, Ra. Guineo Segunda Sección, C.P., Villahermosa 86280, Tabasco, Mexico
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(14), 3243; https://doi.org/10.3390/molecules29143243
Submission received: 3 June 2024 / Revised: 4 July 2024 / Accepted: 7 July 2024 / Published: 9 July 2024
(This article belongs to the Special Issue Metabolites of Biofunctional Interest from Plant Sources)
Browse Figures
Review Reports Versions Notes

Abstract

:
Chysobalanus icaco L. (C. icaco) is a plant that is native to tropical America and Africa. It is also found in the southeast region of Mexico, where it is used as food and to treat certain diseases. This study aimed to carry out a phytochemical analysis of an aqueous extract of C. icaco seed (AECS), including its total phenol content (TPC), total flavonoid content (TFC), and condensed tannins (CT). It also aimed to examine the antioxidant and metal-ion-reducing potential of the AECS in vitro, as well as its toxicity and anti-inflammatory effect in mice. Antioxidant and metal-ion-reducing potential was examined by inhibiting DPPH, ABTS, and FRAP. The acute toxicity test involved a single administration of different doses of the AECS (0.5, 1, and 2 g/kg body weight). Finally, a single administration at doses of 150, 300, and 600 mg/kg of the AECS was used in the carrageenan-induced model of subplantar acute edema. The results showed that the AECS contained 124.14 ± 0.32 mg GAE, 1.65 ± 0.02 mg EQ, and 0.910 ± 0.01 mg of catechin equivalents/g dried extract (mg EC/g de extract) for TPC, TFC and CT, respectively. In the antioxidant potential assays, the values of the median inhibition concentration (IC50) of the AECS were determined with DPPH (0.050 mg/mL), ABTS (0.074 mg/mL), and FRAP (0.49 mg/mL). Acute toxicity testing of the AECS revealed no lethality, with a median lethal dose (LD50) value of >2 g/kg by the intragastric route. Finally, for inhibition of acute edema, the AECS decreased inflammation by 55%, similar to indomethacin (59%, p > 0.05). These results demonstrated that C. icaco seed could be considered a source of bioactive molecules for therapeutic purposes due to its antioxidant potential and anti-inflammatory activity derived from TPC, with no lethal effect from a single intragastric administration in mice.

Graphical Abstract

1. Introduction

Chrysobalanus icaco L. (C. icaco) is a plant species distributed in both tropical America and Africa. It is part of the Chrysobalanaceae family and is known as “caco” in southeastern Mexico. This plant can adapt remarkably to diverse habitats, such as lowland jungles, mangroves, savannahs, and beach vegetation [1]. The ripe fruits of this plant are commonly used to make preserves, jellies, and refreshing drinks [2,3]. In traditional medicine in Mexico, this plant’s seeds, roots, and leaves are used to control blood glucose and body weight through infusion and decoction, among other preparations [4,5]. Moreover, this plant has been used to treat diseases, such as leukorrhea, hemorrhages, malaria, and gastrointestinal problems [6,7,8]. There is also scientific evidence of its potential use as an antioxidant agent [9].
Although there is limited information available regarding the potential benefits of the Chrysobalanus genus, several taxonomic species have been identified as containing secondary metabolites (SMs), specifically phenolic compounds, such as anthocyanins, gallic acid, quercetin, botulinum acid, kaempferol, and their derivatives. These compounds are found in various parts of the plant and are generally responsible for the biological activities that have been described and proven for this species, and are used in herbalism [10]. The seeds of the plant are also a rich source of essential minerals, such as potassium, magnesium, calcium, and sodium. Furthermore, terpenoids, including diterpenes and triterpenes, as well as phytosteroids, have been discovered in Chrysobalanus species [3,11,12].
SMs present in plants beneficially impact the various pathophysiological mechanisms by regulating the differentiation/maturation of inflammatory cells and their secretory effects [13]. This has been related to the possible prevention of non-transmissible chronic diseases (NTCD), including heart disease, atherosclerosis, rheumatoid arthritis, diabetes, cancer, and autoimmune diseases. The SMs found in C. icaco that have been identified with anti-inflammatory and antioxidant effects are mostly flavonoids [14], alkaloids, and phytosterols, in addition to polyunsaturated fatty acids [15], vitamins, and minerals [16].
Venancio et al. [17] evaluated the in vivo anti-inflammatory activity of a C. icaco fruit extract and reported a decrease in biomarkers (TNF-α, IL-1β, IL-6, and NF-kB1) at a concentration of 20.0 µg/mL GAE. Regarding previous studies on the biological activity of C. icaco seed and its toxicological and inflammatory effects, Ribeiro et al. [18] reported the acute toxicity of aqueous extracts of leaves with a median lethal dose (LD50) of >2 g/kg when administered at single doses by the intragastric route in mice. This indicates that the consumption of leaves in the form of tea could be potentially safe for humans over short periods of time (<1 week) at low quantities.
Various plant species and products are used to treat inflammatory and infectious diseases. These treatments come in the form of infusions, plasters, or creams, and are prepared using different plant parts such as leaves, stems, seeds, roots, and flowers [19]. However, most of these products lack toxicological studies to support their safety and effectiveness when used by the human population. For instance, C. icaco seed has not undergone any such studies to date. Therefore, the present study aimed to evaluate the potential of an aqueous extract of C. icaco seeds (AECS) as an antioxidant and metal-reducing agent. The study also aimed to determine the AECS’s acute toxicity (14 days) and its anti-inflammatory effect using the carrageenan-induced model of subplantar acute edema in mice.

2. Results

2.1. Phytochemical Content

Table 1 demonstrates that the AECS had a higher TPC content (124.14 ± 0.32 mg of gallic acid equivalents per g of the extract (GAE/g of the extract)) compared with the values reported for C. icaco seed infusions in previous studies (14.53 ± 3.80 mg GAE/g extract) [19]. However, the TPC values of Portuguese almonds (Prunus dulcis) and aqueous extracts of Castile walnut (Juglans regia) reported lower results for methanolic extracts (3.47 ± 0.17 mg GAE/g of the sample) and aqueous extracts (0.26 ± 0.55 mg GAE/g of the sample, respectively) [20,21]. These studies were compared with the present study due to the similarity in the seeds’ botanical characteristics (hard woody pericarp) and their rich essential oil content.
The AECS had a flavonoid content of 1.65 ± 0.02 mg of quercetin equivalents per g of the extract (mg EQ/g extract) (Table 1). This value was higher than that reported for the methanolic extracts of almond trees (Prunus dulcis), which showed concentrations of 2.82 ± 0.11 µg catechin equivalent/g fresh weight [22]. However, in a study conducted by da Silva et al. [10], a higher TFC (6.64 ± 1.08 mg catechin equivalent/g sample) was reported for hydroalcoholic leaf extracts of C. icaco compared with the AECS evaluated in this study. This indicates that a greater concentration of phenolic compounds can be found in this anatomical part of this species; therefore, greater beneficial biological activity was inferred. The CT assay allows the quantification of complex SMs that have polyphenolic chemical structure such as tannins, which are commonly found in fruits as natural pigments and in the seeds of various plants, and have demonstrated a range of health benefits, including antioxidant, anti-inflammatory, antibacterial, and anticancer properties. They have also shown potential in managing obesity as an alternative treatment [23]. CTs are biosynthesized by the polymerization of flavan-3-ol units, such as catechin, epicatechin, or leucocyanidin, which are linked by a C-C bond and lack a carbohydrate nucleus [24]. The amount of CT present in an extract can vary depending on the extraction method used. In this study, CT (0.910 ± 0.01 mg of catechin equivalents per g of the extract (mg EC/g of extract)) in the AECS was found to be lower [25] than the values shown for extracts of hazelnut (Corylus avellana L.) using acetone–water (80:20 v/v) as extraction solvent. The authors attributed this to the strong interaction between the polarity of the solvent and that of the SM, mainly its glycosylated polyphenolic components, such as tannins.

2.2. Antioxidant Potential In Vitro

After measuring the amount of SM in the AECS, the next tests focused on evaluating its antiradical properties using the DPPH and ABTS methods. Both tests showed a concentration-dependent effect, with IC50 values of 0.050 and 0.074 mg/mL, respectively (Table 1). Quantified compounds in the AECS, such as polyphenols, flavonoids, and tannins, have antioxidant properties, since all of them can donate electrons or hydrogen atoms to stabilize free radicals.
A previous study evaluated the antioxidant potential of hazelnut seeds’ ethanolic extracts in vitro [26], where the researchers used a 0.1 mg/mL concentration and obtained inhibition values of 35.79 ± 0.6% for DPPH and 31.52 ± 1.3% for ABTS. However, in the current study, higher inhibition percentages were observed for the AECS at same 0.1 mg/mL concentration on DPPH (76.086 ± 0.33%), and ABTS (63.33 ± 0.58%). Another study evaluated the antioxidant potential of mature C. icaco seeds in vitro using DPPH at a concentration of 0.5 mg/mL and obtained an inhibition percentage of 60.1%, which was lower than the percentage obtained in this study [19]. Furthermore, in a different study, an IC50 of hazelnut (Corylus avellana L.) extracts was reported to be 1.01 mg/mL for DPPH, which is a higher concentration than that used in the current study (0.05 mg/mL) [27]. This suggests the AECS showed more significant antioxidant potential in vitro for inhibition of free radicals.
During the FRAP assay, the AECS exhibited an IC50 value of 0.49 mg/mL, which was lower than that reported by Locatelli et al. [28], who obtained IC50 values of 4.93 mg/mL and 1.01 mg/mL for acetone and methanolic extracts of hazelnut, respectively. Therefore, it can be concluded that the reducing effect of the AECS was greater. The IC50 values represent the minimum mg of sample/mL needed to inhibit the final concentration of the evaluated radical by 50%, or to reduce the ferric ions to a ferrous form. Thus, the lower the IC50, the greater is its antioxidant potential.

2.3. Phytochemical Profiling by FIA-ESI-FTICR-MS

Table 2 presents the primary bioactive compounds of the AECS in both positive and negative ionization modes. It is evident that nitrogenous compounds favored ionization in the positive mode, while compounds primarily containing carbon, hydrogen, and oxygen (CHO) were detected in the negative mode [29]. The detected compounds fell within a mass range (m/z) of 50 to 2000 Da (Figure 1). Ten components were identified for both modes (C28H46O15, C36H36O18, C8H10O4, C38H48O22, C39H42N4O12, C10H12N5O6P, C10H12N4O6, C5H8O, C9H12N3O9P, and C17H21N4O9P). Hence, these compounds are proposed to be present in the AECS. The compounds with a higher relative abundance were 2-acetyl-3-isobutanoyl-3,4-di(3-methylbutanoyl) sucrose, (+)-sesaminol 2-O-beta-d-gentiotrioside, deoxyadenosine monophosphate (dAMP), and a reduced flavodoxin, compounds that are classified as acylsugars, lignans, deoxyadenylate, and flavodoxins, respectively.

2.4. Acute Toxicity

During this short-term toxicological study, no abnormal changes in food and water consumption were observed in the animals. However, from 3 h onwards, groups receiving doses of 1 and 2 g/kg body weight showed unspecific signs of toxicity, such as piloerection, with frequencies of 100% (6/6 mice) and 83.33% (5/6 mice), and tachycardia (100% and 83.33%) after a single intragastric administration of the AECS. On the other hand, those receiving a dose of 500 mg/kg demonstrated behavior similar to that of the control group, starting from 4 h (Table 3).
Studies have been conducted to determine the acute toxicity of an aqueous extract of C. icaco leaves in both single and repeated doses over a period of 28 days. The acute toxicity results showed an LD50 value of >2 g/kg by the intragastric route in both male and female Swiss mice [18]. However, there is a lack of studies evaluating the toxicity of the seed extract. Ogbonnia et al. [30] evaluated the acute toxicity of Parinari curatellifolia seeds (belonging to the Chrysobalanaceae family) in Wistar rats, where the authors reported a LD50 value of 7.27 g/kg body weight. This showed that this seed is slightly toxic at high doses in a single administration. The LD50 values of both studies were greater than the 2 g/kg body weight estimated for this study. Nonetheless, according to the guidelines described by the TG423 of the OECD, doses above 2 g/kg of body weight are rejected according to the precepts of bioethics and because such doses do not emulate a single dose consumed by human beings.
Lethality is a crucial variable in evaluating the toxicity of new molecules in a preclinical stage. However, during this study, no deaths were registered within 14 days after a single intragastric administration of the AECS at the three tested doses. As a result, the LD50 value was greater than 2 g/kg. The increase in the body weight of the AECS-treated mice of all groups was lower than that of the healthy control group after administration of the vehicle. However, this difference was not statistically significant (p > 0.05), which suggests that consuming the AECS could be safe for humans in a single oral dose in lower quantities.

2.5. Relative Weight and Analysis of Organs (Liver, Spleen, and Kidneys)

Another way to evaluate toxicity is by analyzing the vital organs. The results of the present study showed no changes in the color and total weight of the liver, spleen, and kidneys compared with the control group. However, after calculation, the relative weight of these organs in the AECS-treated animals at doses of 2, 1, 0.5 g/kg body weight did not show any changes (p < 0.05) compared with the control group’s values (Table 4). This indicated that there was no increase in their size from a single intragastric administration of the AECS in healthy mice. Therefore, no macroscopic evidence was observed that indicated an inflammatory process.

2.6. Anti-Inflammatory Activity In Vivo

In the present study, the anti-inflammatory activity of the AECS was evaluated by a carrageenan-induced model of acute edema in the paws of mice. Table 4 presents the results where the AECS inhibited the growth of edema in the early phase of the model (1 h) by 18.14%, 32%, and 42% at doses of 150, 300, and 600 mg/kg, respectively, compared with the untreated carrageenan control group (0.62 ± 0.02 mm). These values were statistically similar to indomethacin’s in the same initial stage (32.30%).
On the other hand, in the late stage of the model (5 h), the three doses of the AECS showed the same inhibition potential (≈53%) compared with the mice with acute edema administered only the vehicle (1.06 ± 0.04 mm). The results for the AECS-treated mice were statistically similar to those treated with indomethacin (59%) at the same time (Table 5).
Previous studies have shown that extracts from the bark of C. icaco exhibited anti-inflammatory activity in murine models at three different doses (100, 200, and 400 mg/kg body weight) [30]. The results showed that at 400 mg/kg a higher percentage of inhibition of edema (53%) was generated, which was similar to that of indomethacin (69%). The results from the previous experiment are consistent with the findings of the present study.

3. Discussion

The seeds of diverse plants have been reported to be a rich source of dietary fiber and to contain several bioactive SMs such as phenolic acids, flavonoids, tannins, and anthocyanins, as well as sterols, tocopherols, vitamins, and minerals such as iron, selenium, and magnesium. They could act in the organism as cofactors of vital enzymes [26]. These compounds are known also for their antioxidant properties and their ability to promote regulatory physiological effects during disease-related dysregulation. They have been associated with the prevention or delay of the development of chronic degenerative diseases, such as certain types of cancer, coronary and cardiovascular diseases, obesity, diabetes, atherosclerosis, inflammation, and other diseases associated with oxidative stress [31].
Wang et al. [32] reported a significant correlation (p < 0.05) between seed coats and higher TPC, as well as the in vitro antioxidant potential. Therefore, the higher TPC observed in this study is likely to be due to the use of whole seeds in the extraction process. The content of SM in a sample largely depends on the solvent used and the extraction method. Advanced extraction technologies and organic compounds, with high polarity, and solvents such as methanol, ethanol, and hydroalcoholic solutions have been proven to yield higher concentrations of SM from plants after extraction [33,34,35]. Moreover, the final yield and concentration may still vary depending on the material used and the conditions of extraction [36]. This study used water as the solvent and ultrasound-assisted extraction (UAE), where ultrasonic vibrations facilitated the rupture of the cell membranes and therefore the greater release of SM. Conventional methods were not used, which can result in high shear stresses, pressure, and very high temperatures, ultimately causing the collapse of the bubbles [37]. This technique has been shown to release more easily glycosylated SMs (bound phenols), leaving the free aglycones (free phenols) to be detected and quantified more easily by in vitro techniques and increasing their possible biological activities [38].
The phenolic compounds, flavonoids, and condensed tannins present in C. icaco seeds depend on various factors such as the climate, the fruits’ size and stage of maturity, the variety, the methods of processing and storage, and extraction techniques [39]. Drying the seeds can prevent microbial deterioration and cause enzymatic and non-enzymatic oxidative changes that can alter the phenolic compounds’ chemical structure and their bioactivity as well [40]. Phenolic compounds contain unsaturated bonds (-C=C-) and hydroxyl groups (-OH), which give them strong antioxidant properties that help stabilize free radicals in their chemical structure [41]. However, this characteristic also makes them vulnerable to denaturation due to exposure to high temperatures, light changes in, pH, and the action of enzymes and certain metal ions, which can reduce or eliminate their antioxidant potential [42].
The TPC of medicinal plant extracts is closely linked to their antioxidant potential when tested in vitro. This is because higher TPC values indicate that the extracts can inhibit free radicals in a better manner [43]. However, it is important to note that phenolic compounds can sometimes act as pro-oxidants under specific conditions, mostly high concentrations and time of exposure [44]. On the other hand, they can also have a reducing effect on metal ions that are in their oxidized form. This can maintain or even enhance their catalytic activity, decreasing their capacity to form free radicals from peroxides, depending on the nature of the metal ions, their reducing potential, pH, and solubility [45].
The high TPC and TF in the AECS provide its well-known in vitro antioxidant potential. According to reports, polyphenolic compounds can bind with plant proteins and polysaccharides, forming covalent and non-covalent associations [46]. The presence of CT in the AECS is due to its union with fibrous cells. Some nuts (hazelnuts) are reported to contain 168 to 378 times the TPC (flavan 3-ols), while hazelnut seeds have 51.9–203.1 mg EAG/g sample, found mainly in its coat [47]. Analysis of the AECS identified compounds such as flavonoids, lignans, xanthones, aldehydes, and flavodoxin, as well as 2-acetyl-3-isobutanoyl-3,4-di(3-methylbutanoyl) sucrose, which belongs to the group of acyl sugars. The FIA-ESI-FTICR-MS technique was used to determine the molecular mass of these compounds with precision [29].
Research has shown that compounds found in the AECS, such as (+)-sesaminol 2-O-beta-d-gentiotrioside, xanthosine, and cyanidin 3-O-(6-O-p-coumaroyl) glucoside-5-O-glucoside, exhibit antioxidant activities [48], and have hypoglycemic and neuroprotective properties [49]. On the other hand, reduced flavodoxin and dAMP have anti-inflammatory effects by inhibiting NF-κB, maintaining the redox balance, and providing resistance to oxidative stress [50,51].
Throughout history, people have used medicinal plants extensively to treat various diseases. These important sources of pharmacological bioactive SM are used as alternative remedies in traditional medicine [52]. These plants can be used to treat both acute and chronic conditions [53]. However, conducting acute toxicity tests on murine models for plants used in traditional medicine is crucial. This is because some species may cause severe poisoning in humans that can be lethal [54]. Additionally, it has been observed that data on lethal doses in mice are more suitable for predicting toxic effects in humans [55]. To evaluate the acute toxicity according to OECD Directive 423 [56], the single-dose toxicity method was used. This method analyzed the toxicological status of the AECS depending on the mortality and morbidity status of the animals.
Body weight is also a crucial factor, as it indicates the adverse side effects of chemical substances, as it is a non-specific sign of toxicity. Studies have suggested that animals cannot lose more than 10% of their initial body weight [52]. The changes in the weight of internal organs and their relative weight ratio can help determine their normal or pathological state. In the analysis carried out on the experimental animals used in this study, there were no changes or abnormal growth in the liver, spleen, and kidneys of the AECS-treated groups compared with the control group. However, conducting a toxicological study at repeated doses for 28 days is recommended to determine whether the AECS causes changes in the relative weight of the liver, as well in the function of these vital organs. Further detailed and specific toxicological investigations of this AECS are necessary to establish its safety.
For acute inflammation caused by an injection of carrageenan, the major mechanism of action is through activation of the Bcl10, NF-kB, and IkBa pathways. This leads to the release of inflammatory mediators in two phases. In the first phase, or early phase, (1 to 3 h after injection), vasodilators such as histamine, serotonin, bradykinin, and cytokines are activated and released. Additionally, nitric oxide synthase (iNOS) is activated, and nitric oxide (NO•) is produced, increasing blood flow to the inoculation site. After this second phase (3 to 6 h), biosynthesis of prostaglandins E2 (PGE2) occurs due to the activation of induced cyclooxygenase (COX-2) enzymes, and lysosomes at 5 h, leading to the maximum formation of acute subplantar edema [57,58]. In this model, indomethacin was used, which is an anti-inflammatory drug that inhibits the enzyme cyclooxygenase (COX-2) induced in the arachidonic acid (AA) metabolic pathway. The carrageenan model involves the activation of enzymes that participate in the metabolism of arachidonic acid (AA), namely 5-lipoxygenase (5-LOX) and COX-2, with greater activity of the latter [59,60]. This model can be used to evaluate the anti-inflammatory potential of new substances on the enzymatic pathway of non-oxygen-dependent acute inflammation and biosynthesis of PGE2.
Inflammation is the body’s natural response to harmful stimuli caused by biological, chemical, and physical agents. This response can be acute, which means it occurs in the short term and is characterized by the dilation of blood vessels, increased permeability of blood vessels, swelling, migration of leukocytes and other inflammatory mediators, and self-regulation when the stimulus is eliminated, favoring the recovery of homeostasis [60]. These acute mediators include vasoactive amines, derivatives of arachidonic acid (non-oxygen-dependent pathway), and cytokines. Moreover, during this early stage of inflammation, they occur through macrophages (phagosomes) activated by reactive oxygen species (ROS) (oxygen-dependent pathway), which are intended to eliminate pathogens but can cause cellular damage in tissues and an alteration in homeostasis. Macrophages play a vital role in the initiation and propagation of acute inflammatory responses, biosynthesizing various ROS and proinflammatory cytokines (interleukin TNF-α, 1L-1β, and IL-6), leading to an accumulation of oxidative damage in tissues [61].
The excessive production of reactive oxygen and nitrogen species (ROS/RNS) leads to oxidative stress, which, in turn, causes the oxidation of biomolecules, resulting in the release of endogenous damage-associated molecular patterns (DAMPs) such as enzymes (neutral proteases, acid hydrolases, phosphatases, and lipases, among others), reactive species (superoxide, hydrogen peroxide, hydroxyl radicals, and hypochlorous acid, among others), and chemical mediators (eicosanoids, cytokines, chemokines, and nitric oxide), inducing tissue damage and oxidative stress by disrupting cellular homeostasis and triggering an inflammatory response [62,63].
To counteract oxidative damage, there are enzymatic or endogenous antioxidant systems (superoxide dismutase, catalase, and glutathione peroxidase) and non-enzymatic or exogenous antioxidant systems (Vitamin E, Vitamin C, beta-carotene, phenolic compounds, terpenes, and saponins, among others) that protect by neutralizing or eliminating reactive species, reducing the damage caused by oxidative stress, and inhibiting the inflammatory response [64].
According to this study’s findings, the AECS showed an anti-inflammatory effect that was not dose-dependent. It was attributed to the AECS’ antioxidant potential and the combined action of its different SMs, which could help remove the free radicals generated by neutrophils, macrophages, and endothelial cells during the acute inflammatory process. They may also inhibit enzymes such as COX-2 and 5-LOX that are expressed during acute inflammatory processes, thereby reducing the synthesis of PGE2 in the late phase of the experimental model, reducing the growth of edema [30]. Previous research has shown that non-steroidal anti-inflammatory drugs (NSAIDs) can inhibit both inflammatory and non-inflammatory processes when used repeatedly. NSAIDs can affect the activity of cyclooxygenase-1 (COX-1), which regulates various functions such as gastrointestinal protection, vascular homeostasis, and platelet function [13,65,66]. Therefore, future studies are required to focus not only on the isolation and evaluation of the in vitro antioxidant potential of the main SMs of the AECS and their possible anti-inflammatory effect, but also to determine the selectivity in the inhibition of COX-2 and not of the gastroprotective isoform (COX-1).

4. Materials and Methods

4.1. Biological Materials and Preparation of C. icaco Flour

Mature fruits of C. icaco were gathered from Paredón Bay, located in the municipality of Tonalá Chiapas, México (16°03′03″ N 93°52′00″ W). The fruits were washed and disinfected. White, cottony pulp was removed. Seeds with their coat were then dried in a convection oven at 40 °C for 72 h. They were subsequently ground into flour using a Krups grinder and sieved with a 14-mesh sieve to achieve a uniform particle size of 1.41 mm. The flour was defatted with hexane using the Soxhlet method (1:10) for 6 h, and then placed in trays at room temperature for 12 h to eliminate any excess solvent. Finally, the solvent-free dried sample was stored in polyethylene bags until use.

4.2. Preparation of the Aqueous Extract of C. icaco Seed

For this, 100 mg of defatted flour was weighed and added to 10 mL of distilled water, resulting in a 10 mg/mL concentration. The mixture was then placed in an ultrasonication bath (Ultrasonic Cleaner, 010S, CGOLDENWALL, Zhengzhou, China) at 42 Khz for 30 min [67,68]. After that, the mixture was filtered through a nylon filter with a pore size of 22 µm, poured into amber vials, and stored in the refrigerator at 4 °C until use.

4.3. Determination of Total Phenolic Content, Flavonoids, and Condensed Tannins

The following methods were used to determine the total phenol content (TPC), total flavonoid content (TFC), and condensed tannins (CT) in the AECS.
For the TPC, a modified version of the Folin–Ciocalteu method was used, as described by Borges-Martínez et al. [69]. Gallic acid (GA) was used at concentrations ranging from 0.02 to 0.1 mg/mL (y = 5.4x − 0.0294, R2 = 0.9889). The AECS samples were analyzed in triplicate and read at 765 nm. The results were reported in mg of GA equivalents per gram of the extract (mg GAE/g of the extract).
A method developed by Ortega-Medrano et al. [70] was used for the TFC assay with some modifications. For this, 1 mL of the AECS was mixed with 300 µL of 5% (w/v) sodium nitrite and 300 µL of AlCl3 after 5 min. The mixture was allowed to stand for 6 min before 2 mL of 1 M NaOH was added. Finally, 250 µL of the mixture was deposited on microplates, and the absorbance was read at 510 nm. A standard curve of quercetin at concentrations ranging from 0.1 to 0.5 mg/mL (y = 2.4917x − 0.1017, R2 = 0.9961) was used to calculate the total flavonoid content. The results were expressed as mg of quercetin equivalents per gram of the extract (mg EQ/g of the extract).
A modified version of the method described by Ortega-Medrano et al. [70] was used for measuring CT. For this, 100 μL of 1% vanillin, 100 μL of AECS, and 100 μL of 25% (v/v) sulfuric acid were mixed and incubated at 30 °C for 15 min. Themixture was read at 500 nm using a multiwell plate reader. A standard curve of catechin at concentrations ranging from 25 to 100 µg/mL (y = 0.0012x + 0.0568, R2 = 0.9934) was used to calculate the CT content. The results were expressed as milligrams of catechin equivalents per gram of the extract (mg EC/g of the extract).

4.4. Antioxidant Potential In Vitro

4.4.1. DPPH Inhibition Assay

The study evaluated the antioxidant potential of the plant in vitro by inhibiting the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical, following the method described by Medina-Medrano et al. [71]. A multiwell plate reader (Multiskan Go Thermo Scientific, Waltham, MA, USA) was used for this purpose. To perform the experiment, 100 μL of the DPPH (62 µg/mL) reagent (Sigma-Aldrich D9136-5G, St. Louis, MO, USA) dissolved in ethanol was mixed with 100 μL of the AECS at different concentrations (0.02 to 0.1 mg/mL) and kept in the dark at room temperature for 20 min. The samples were then read at 517 nm, and all measurements were taken in triplicate (n = 3). The percentage of inhibition was calculated using the following formula,
DPPH inhibition (%) = [(A)blank − (A)sample/(A)blank)] × 100
where (A)blank represents the absorbance of the radical solution (DPPH solution + absolute methanol), and (A)sample is the absorbance of the test sample (DPPH solution + AECS).
The antioxidant potential was measured in terms of IC50, expressed in mg/mL. The mean inhibitory concentration (IC50) was calculated from a graph showing the percentage of inhibition against the extract concentration and was also expressed in mg/mL. The IC50 represents the concentration of the sample needed to reduce the initial concentration of the radical by 50%.

4.4.2. Scavenging of ABTS+ Radicals

According to Medina-Medrano et al. [71], the 2,2′-azino-bis [3-ethylbenzothiazoline-6-sulfonic acid] (ABTS) radical cation discoloration assay was performed with some modifications. To produce ABTS+, the radicals (7 mM in water) were mixed with potassium persulfate (140 mM) in the dark at room temperature for over 12 h. Before the assay, the solution was diluted in distilled water and incubated at room temperature, resulting in an absorbance of 0.70 ± 0.01 at 734 nm. The samples (0.02–0.1 mg/mL) were incubated for 20 min with 100 µL of the ABTS+ radical cation solution, and the absorbance was measured at 734 nm. All determinations were performed in triplicate (n = 3). The antioxidant potential was expressed in terms of IC50 in mg/mL.
The percentage of inhibition of the ABTS+ radical was calculated using the equation below
ABTS inhibition (%) = [(A)blank − (A)sample/(A)blank)] × 100
where (A)blank represents the absorbance of the blank (ABTS+ solution + water), and (A)sample represents absorbance of the test sample (ABTS+ solution + AECS solution).

4.4.3. Reducing Power

The ferric-reducing antioxidant power (FRAP) was measured according to Ramos et al. [72], using a multiwell plate reader (Multiskan Go, Thermo Scientific, USA). The AECS (75 to 300 μL at 1 mg/mL) was mixed with 250 μL of a phosphate buffer (0.2 M, pH 6.6) and 250 μL of potassium ferrocyanide (1% w/v). The mixture was incubated (50 °C/20 min), and 250 μL of trichloroacetic acid (10% w/v) was added. The mixture was centrifuged (482× g, 25 °C, 10 min), and 300 μL of the supernatant was taken and mixed with 300 μL of deionized water and 60 μL of ferric chloride (0.1% w/v). Then the absorbance was recorded at 700 nm. A blank reagent was prepared with distilled water instead of the AECS. The increase in the absorbance of the reaction mixture indicated an increase in the reducing power. All determinations were performed in triplicate (n = 3). The antioxidant potential was expressed in terms of the IC50 in mg/mL. The ferric-reducing antioxidant power was calculated using the following equation:
Reducing effect (%) = [(A)sample − (A)blank)/(A)sample] × 100

4.5. Determination of the Phytochemical Composition by FIA-ESI-FTICR-MS Analysis

Ultrahigh-resolution mass spectra were obtained using a Solarix XR 7T (Bruker, Bremen, Germany) through flow injection analysis–Fourier transform ion cyclotron resonance mass spectrometry (FIA-ESI-FTICR-MS). The candidate metabolites’ names and structures were identified using Bruker Compass MetaboScape 2022b v. 9.0.1. The structural formulas of the compounds were retrieved from ChemSpider and the PubChem database in accordance with the conditions described by Granados-Balbuena [29].

4.6. In Vivo Evaluation

Female CD1 mice weighing 25 ± 5 g from Bioterio PROPECUA S.A. were used for evaluating the toxicity and anti-inflammatory effects of the studied plant in vivo. Animals were acclimatized for a week before the experiments and were kept in a controlled environment with 12-h light/dark cycles at 25 ± 2 °C and 55–80% RH. Purified water and rodent chow were provided ad libitum. Animals were cared for and maintained following the recommendations and guidelines of the International Committee for the Care and Use of Laboratory Animals (CICUAL) and was registered at https://preclinicaltrials.eu/database/view-protocol/519 (accessed on 6 July 2024) with the registration number PCTE0000519. The project was also reviewed by the Bioethics Committee of the National School of Biological Sciences of the National Polytechnic Institute (ENCB-IPN), registration number ENCB/CEI/085/2023 CONBIETICA-09-CEI-002-20190327, and El Colegio de la Frontera Sur (registration: CEI/2023/3798/05)

4.6.1. Assessment of Acute Toxicity

According to the OECD’s test guidelines [56], this test was conducted following the TG 423 procedure. Three mice (n = 3) were randomly assigned to each of four experimental groups. Mice were fasted for 12 h prior to being administered the AECS via the intragastric (i.g.) route. The control group (Group 1) was given a single i.g. administration of the vehicle (Tween 80 and water at a 1:9 ratio) at a dose of 10 mL/kg, while Groups 1–3 were given a single i.g. administration of the AECS at doses of 500, 1000, and 2000 mg/kg, respectively. The volume of resuspended extract which was administered was 10 mL of the extract per kg of body weight. After administration, the mice were monitored for the first 6 h for any signs of neurotoxicity, such as a decrease in locomotion, aggressiveness, or reaction to a stimulus (social interactions), as well as piloerection and aspects of the feces. The frequency of the signs was recorded, along with gain in body weight (in grams) on Days 3, 7, 9, and 14 after administration. Their basal weight (Day 0) was used as a reference for comparison. Any deaths that occurred during the experiment were counted and necropsies were conducted. On the final day, the surviving mice were euthanized by cervical dislocation, and the liver, spleen, and kidneys were removed for macroscopic observation to identify pathological lesions. Finally, the relative weight (%) of these major organs was calculated [73]. As indicated in the procedural guides, depending on the number of deaths, the experiment was repeated under the same conditions and groups with three mice for each one (n = 3), until there was a total of six per group. This was carried out to establish the LD50 within the toxicity categories on the basis of their lethality.

4.6.2. Carrageenan-Induced Model of Subplantar Edema

The potential anti-inflammatory effects of the AECS during an acute phase of inflammation were evaluated using a method described by Gutiérrez-Rebolledo et al. [73]. The study involved five groups of experimental animals (n = 7): Group (1), carrageenan control; Group (2), indomethacin (10 mg/kg); Groups (3–5), AECS at doses of 150, 300, and 600 mg/kg, respectively. Groups 2–5 were administered the treatments by the i.g. route 1 h before the irritant agent, while Group 1 received the vehicle only (Tween 80:water (1:9, 10 mL restored extract/kg)). After this, all groups (1–5) were injected with 2% carrageenan (20 µL) in isosterile saline (ISS) into the subplantar pad.
Development of subplantar edema was measured at different times after administering the irritant agent (1, 3, 5, and 7 h) using a digital vernier meter (Mitutoyo model 293–831). The formation of edema was calculated on the basis of the difference in the diameters at each hour of measurement (Td) in relation to the basal time before the injection of the irritant agent (T0). The percentage of inhibition (%) was calculated for each treatment group (2–5) by comparing them with the data from Group 1 at the same time. The results were calculated using the following formula:
% inhibition = [(Td − T0) carrageenan − (Td − T0) treated/(Td − T0) carrageenan] × 100.

5. Conclusions

Seeds accumulate secondary metabolites, including phenolic compounds, that possess biological activities. The extraction of bioactive compounds from seeds allows us to obtain high concentrations of these compounds. The AECS from C. icaco seeds was found to contain high concentrations of phenolic compounds and exhibit antioxidant potential in vitro by inhibiting free radicals and reducing metal ions. Additionally, it is potentially safe for human consumption, as it did not show lethality in acute toxicity tests in CD1 mice by the intragastric route. However, further research is required to investigate the safety of repeated doses in a 28-day toxicological study.
In an acute model induced by carrageenan at three doses, AECS decreased inflammation in the experimental animals. This could be attributed to its antioxidant potential and the different compounds contained in the extract, which work together to eliminate free radicals and inhibit enzymes during the acute inflammatory process. In future research, it is proposed that the compounds present in the AECS should be identified and the mechanisms by which the extracts regulate the inflammatory properties of other diseases related to oxidative stress should be studied.

Author Contributions

A.A.-O., conceptualization, methodology, formal analysis, investigation, writing—original draft; C.J.-M., validation of the methodology, formal analysis, resources, writing—review and editing, visualization, supervision, project administration, funding acquisition; G.A.G.-R., methodology, software, validation, formal analysis, resources, data curation, writing—review and editing, funding acquisition; L.J.C.-R., methodology, resources, writing—review and editing, funding acquisition; Z.E.O.-V., methodology, writing—review and editing, funding acquisition; R.M.-E., writing—review and editing, supervision, funding acquisition; Y.C.-N., formal analysis, funding acquisition; writing—review and editing; X.M.S.-C., conceptualization, validation, formal analysis, investigation, resources, data curation, writing—review and editing, visualization, supervision, project administration, funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The animal study protocol was approved by the Ethics Committee of the Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional (with the registration number ENCB/CEI/085/2023 CONBIETICA-09-CEI-002-20190327 on 15 April 2023) for studies involving animals.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

Abel Arce Ortiz thanks the National Council of Humanities, Science, and Technology (CO-NAHCYT-Mexico) for scholarship No. 619478, and the Research and Postgraduate Secretary (RPS) of the IPN for multidisciplinary project No. 225 and its modules SIP 20231600 and SIP 20240694.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ramírez-Villalobos, M.; Urdaneta-Fernández, A.; Vargas-Simón, G. Tratamientos con ácido indolbutírico y lesionado sobre el enraizamiento de estacas de icaco (Chrysobalanus icaco L.). Agron. Trop. 2004, 54, 203–218. [Google Scholar]
  2. Vargas, C.E.; Mendes, M.F.; Azevedo, D.A.; Pessoa, F.L.; Uller, A.C. Extraction of the essential oil of abajeru (Chrysobalanus icaco) using supercritical CO2. J. Supercrit. Fluids 2010, 54, 171–177. [Google Scholar] [CrossRef]
  3. Onilude, H.A.; Kazeem, M.I.; Adu, O.B. Chrysobalanus icaco: A review of its phytochemistry and pharmacology. J. Integr. Med. 2021, 19, 13–19. [Google Scholar] [CrossRef] [PubMed]
  4. de Oliveira Barbosa, A.P.; de Oliveira Silveira, G.; Cortés de Menezes, I.A.; Rezende Neto, J.M.; Bitencurt, J.; dos Santos Estavam, C.; do Carmo Bion de Lima, A.; Tomazzi, S.M.; Gibara-Guimaraes, A.; Quintans, L.J.; et al. Antidiabetic effect of the Chrysobalanus icaco L. aqueous extract in rats. J. Med. Food. 2013, 16, 538–543. [Google Scholar] [CrossRef] [PubMed]
  5. White, P.A.; Cercato, L.M.; Batista, V.S.; Camargo, E.A.; De Lucca, W.; Oliveira, A.S.; Silva, F.T.; Goes, T.C.; Oliveira, E.R.; Moraes, V.R.; et al. Aqueous extract of Chrysobalanus icaco leaves, in lower doses, prevent fat gain in obese high-fat fed mice. J. Ethnopharmacol. 2016, 179, 92–100. [Google Scholar] [CrossRef] [PubMed]
  6. Ferreira-Machado, S.C.; Rodrigues, M.P.; Nunes, A.P.M.; Dantas, F.J.; De Mattos, J.C.P.; Silva, C.R.; Bezerra, R.J.; Caldeira de Araujo, A. Genotoxic potentiality of aqueous extract prepared from Chrysobalanus icaco L. leaves. Toxicol. Lett. 2004, 151, 481–487. [Google Scholar] [CrossRef]
  7. Silva, I.; Peixoto, A. El abajurú (Chrysobalanus icaco L. y Eugenia rotundifolia Casar.) comercializado en la ciudad de Río de Janeiro, Brasil. Rev. Bras. Farmacogn. 2009, 19, 325–332. [Google Scholar] [CrossRef]
  8. Feitosa, E.; Xavier, H.; Randau, K. Chrysobalanaceae: Traditional uses, phytochemistry and pharmacology. Rev. Bras. Farmacogn. 2012, 22, 1181–1186. [Google Scholar] [CrossRef]
  9. Stephen-Onojedje, Q.O.; Asagba, S.O.; Kadiri, H.E. Assessment of Antioxidant and Polyphenol Profile of Chrysobalanus icaco from Southern Nigeria. Trop. J. Nat. Prod. Res. 2023, 7, 2782–2789. [Google Scholar]
  10. da Silva Pantoja, L.; Trindade, S.; da Silva Carneiro, A.; Silva, J.P.; da Paixa, T.P.; Romeiro, C.F.; de Andrade, M. Computational study of the main flavonoids from Chrysobalanus icaco L. against NADPH-oxidase and in vitro Antioxidant Activity. Res. Soc. Dev. 2022, 11, e5011628542. [Google Scholar] [CrossRef]
  11. Carnevale, N.F.; Pilon, A.C.; da Silva, B.V.; Castro, G.I. Chrysobalanaceae: Secondary metabolites, ethnopharmacology and pharmacological potential. Phytochem. Rev. 2013, 12, 121–146. [Google Scholar] [CrossRef]
  12. Araújo-Filho, H.G.; Dias, J.D.S.; Quintans-Júnior, L.J.; Santos, M.R.; White, P.A.; Barreto, R.S.; Quintans, J.S. Phytochemical screening and analgesic profile of the lyophilized aqueous extract obtained from Chrysobalanus icaco leaves in experimental protocols. Pharm. Biol. 2016, 54, 3055–3062. [Google Scholar] [CrossRef] [PubMed]
  13. Xiao, F.; Farag, M.A.; Xiao, J.; Yang, X.; Liu, Y.; Shen, J.; Lu, B. The influence of phytochemicals on cell heterogeneity in chronic inflammation-associated diseases: The prospects of single cell sequencing. J. Nutr. Biochem. 2022, 108, 109091. [Google Scholar] [CrossRef] [PubMed]
  14. Felgus-Lavefve, L.; Howard, L.; Adams, S.H.; Baum, J.I. The effects of blueberry phytochemicals on cell models of inflammation and oxidative stress. Adv. Nutr. 2022, 13, 1279–1309. [Google Scholar] [CrossRef] [PubMed]
  15. Bezerra, J.L.; Pinheiro, A.V.; de Oliveira, A.M. Cyperaceae species used for the treatment of inflammation: A review of ethnomedicinal, pharmacological, toxicological, and phytochemical evidence. S. Afr. J. Bot. 2022, 150, 1138–1158. [Google Scholar] [CrossRef]
  16. Corte-Real, J.; Bohn, T. Interaction of divalent minerals with liposoluble nutrients and phytochemicals during digestion and influences on their bioavailability—A review. Food Chem. 2018, 252, 285–293. [Google Scholar] [CrossRef] [PubMed]
  17. Venancio, V.P.; Cipriano, P.A.; Kim, H.; Antunes, L.M.; Talcott, S.T.; Mertens-Talcott, S.U. Cocoplum (Chrysobalanus icaco L.) anthocyanins exert anti-inflammatory activity in human colon cancer and non-malignant colon cells. Food. Funct. 2017, 8, 307–314. [Google Scholar] [CrossRef] [PubMed]
  18. Ribeiro, N.E.; Pereira, P.S.; Bezerra de Oliveira, T.; de Arruda, S.M.; Sarmento Silva, T.M.; Delmiro Santana, A.; Silva do Nascimiento, M.S.; Moreno Santisteban, R.; Coelho Teixeira, A.; Goncalves da Silva, T. Acute and repeated dose 28-day oral toxicity of Chrysobalanus icaco L. leaf aqueous extract. Regul. Toxicol. Pharmacol. 2020, 113, 104643. [Google Scholar] [CrossRef]
  19. Villagra, E.; Quintero, E.; Mero, A.; De León, E.G.; Morán-Pinzón, J.A.; Palermo, J.A.; Cano, L.P. Caracterización química y actividad biológica de las hojas y semillas de Chrysobalanus icaco L. (Icaco). Rev. Cubana Plant. Med. 2020, 25, 1–11. [Google Scholar]
  20. Oliveira, I.; Meyer, A.; Afonso, S.; Ribeiro, C.; Gonçalves, B. Morphological, mechanical and antioxidant properties of Portuguese almond cultivars. J. Food Sci. Technol. 2018, 55, 467–478. [Google Scholar] [CrossRef]
  21. Ogunmoyole, T.; Kade, I.J.; Korodele, B. In vitro antioxidant properties of aqueous and ethanolic extracts of walnut (Juglans regia). J. Med. Plant Res. 2011, 5, 6839–6848. [Google Scholar] [CrossRef]
  22. Oliveira, I.; Meyer, A.S.; Afonso, S.; Sequeira, A.; Vilela, A.; Goufo, P.; Trindade, H.; Goncalves, B. Effects of different processing treatments on almond (Prunus dulcis) bioactive compounds, antioxidant activities, fatty acids, and sensorial characteristics. Plants 2020, 9, 1627. [Google Scholar] [CrossRef] [PubMed]
  23. Han, S.; Kong, X.; Xia, S.; Jia, B.; Dong, M.; Gan, L. UV light-driven controlled photodegradation of condensed tannins from larch bark. Ind. Crops Prod. 2022, 177, 114403. [Google Scholar] [CrossRef]
  24. Olivas-Aguirre, F.J.; Wall-Medrano, A.; González-Aguilar, G.A.; López-Díaz, J.A.; Álvarez-Parrilla, E.; Rosa, L.A.; Ramos-Jimenez, A. Hydrolyzable tannins; biochemistry, nutritional & analytical aspects and health. Nutr. Hosp. 2015, 31, 55–66. [Google Scholar]
  25. Pelitli, E.P.; Janiak, M.A.; Amarowicz, R.; Alasalvar, C. Protein precipitating capacity and antioxidant activity of Turkish Tombul hazelnut phenolic extract and its fractions. Food Chem. 2017, 218, 584–590. [Google Scholar] [CrossRef] [PubMed]
  26. Kumar, A.; Kumar, P.; Koundal, R.; Agnihotri, V.K. Antioxidant properties and UPLC–MS/MS profiling of phenolics in jacquemont’s hazelnut kernels (Corylus jacquemontii) and its byproducts from western Himalaya. J. Food Sci. 2016, 53, 3522–3531. [Google Scholar] [CrossRef] [PubMed]
  27. Pelvan, E.; Olgun, E.O.; Karadag, A.; Alasalvar, C. Phenolic profiles and antioxidant activity of Turkish Tombul hazelnut samples (natural, roasted, and roasted hazelnut skin). Food Chem. 2018, 244, 102–108. [Google Scholar] [CrossRef] [PubMed]
  28. Locatelli, M.; Travaglia, F.; Coïsson, J.D.; Martelli, A.; Stévigny, C.; Arlorio, M. Total antioxidant activity of hazelnut skin (Nocciola Piemonte PGI): Impact of different roasting conditions. Food Chem. 2010, 119, 1647–1655. [Google Scholar] [CrossRef]
  29. Granados-Balbuena, S.Y.; Díaz-Pacheco, A.; García-Meza, M.G.; Tapia-López, L.; Cruz-Narváez, Y.; Ocaranza-Sánchez, E. Phytochemical profile of petals from black Dahlia pinnata by flow injection analysis–electrospray ionization–Fourier transform ion cyclotron resonance mass spectrometry. Phytochem. Anal. 2023, 34, 1009–1021. [Google Scholar] [CrossRef]
  30. Ogbonnia, S.O.; Adekunle, A.; Olagbende-Dada, S.O.; Anyika, E.N.; Enwuru, V.N.; Orolepe, M. Assessing plasma glucose and lipid levels, body weight and acute toxicity following oral administration of an aqueous ethanolic extract of Parinari curatellifolia Planch, (Chrysobalanaceae) seeds in alloxan-induced diabetes in rats. Afr. J. Biotechnol. 2008, 7, 2998–3003. [Google Scholar]
  31. Oliveira, T.; Júnior, C.; Mota, F.; Araújo, L.; Maia, M.; Randau, K.; Nascimento, S.; Silva, T.G.D. Anti-inflammatory and Antinociceptive Effects of the Aqueous Extract of the Bark of Chrysobalanus icaco Linnaeus. Br. J. Pharm. Res. 2014, 4, 1253–1268. [Google Scholar] [CrossRef]
  32. Silva, L.B.A.; Pinheiro-Castro, N.; Novaes, G.M.; Pascoal, G.; Ong, T. Bioactive food compounds, epigenetics and chronic disease prevention: Focus on early-life interventions with polyphenols. Food Res. Inter. 2019, 125, 108646. [Google Scholar] [CrossRef] [PubMed]
  33. Wang, R.; Tian, X.; Li, Q.; Liao, L.; Wu, S.; Tang, F.; Shen, D.; Liu, Y. Walnut pellicle color affects its phenolic composition: Free, esterified and bound phenolic compounds in various colored-pellicle walnuts. J. Food Compos. Anal. 2022, 109, 104470. [Google Scholar] [CrossRef]
  34. Xiaokang, W.; Lyng, J.G.; Brunton, N.P.; Cody, L.; Jacquier, J.C.; Harrison, S.M.; Papoutsis, K. Monitoring the effect of different microwave extraction parameters on the recovery of polyphenols from shiitake mushrooms: Comparison with hot-water and organic-solvent extractions. Biotechnol. Rep. 2020, 27, e00504. [Google Scholar] [CrossRef] [PubMed]
  35. Durmus, N.; Kilic-Akyilmaz, M. Bioactivity of non-extractable phenolics from lemon peel obtained by enzyme and ultrasound assisted extractions. Food Biosci. 2023, 53, 102571. [Google Scholar] [CrossRef]
  36. Hazmi, S.A.; Ismail, N.S.; Mohamad, M.; Osman, W.H. Extraction of phenolic and flavonoids compounds from kenaf (Hibiscus cannabinus L.) using ultrasound assisted extraction. Mater. Today Proc. 2023, in press. [Google Scholar]
  37. Pinelo, M.; Rubilar, M.; Jerez, M.; Sineiro, J.; Núñez, M.J. Effect of solvent, temperature, and solvent-to-solid ratio on the total phenolic content and antiradical activity of extracts from different components of grape pomace. J. Agric. Food Chem. 2005, 53, 2111–2117. [Google Scholar] [CrossRef] [PubMed]
  38. Hedayati, S.; Niakousari, M.; Babajafari, S.; Mazloomi, S.M. Ultrasound-assisted extraction of mucilaginous seed hydrocolloids: Physicochemical properties and food applications. Trends Food Sci. Technol. 2021, 118, 356–361. [Google Scholar] [CrossRef]
  39. Ruviaro, A.R.; Barbosa, P.D.; Alexandre, E.C.; Justo, A.F.; Antunes, E.; Macedo, G.A. Aglycone-rich extracts from citrus by-products induced endothelium-independent relaxation in isolated arteries. Biocatal. Agric. Biotechnol. 2020, 23, 2–7. [Google Scholar] [CrossRef]
  40. Arcan, I.; Yemenicioglu, A. Antioxidant activity and phenolic content of fresh and dry nuts with or without the seed coat. J. Food Compos. Anal. 2009, 22, 184–188. [Google Scholar] [CrossRef]
  41. Ferreyra, S.; Bottini, R.; Fontana, A. Temperature and light conditions affect stability of phenolic compounds of stored grape cane extracts. Food Chem. 2023, 405, 2–12. [Google Scholar] [CrossRef]
  42. Pundir, S.; Garg, P.; Dviwedi, A.; Ali, A.; Kapoor, V.K.; Kapoor, D.; Kulshrestha, S.; Ranjan, U.; Negi, P. Ethnomedicinal uses, phytochemistry and dermatological effects of Hippophae rhamnoides L.: A review. J. Ethnopharmacol. 2021, 266, 113434. [Google Scholar] [CrossRef] [PubMed]
  43. Esparza, I.; Cimminelli, M.J.; Moler, J.A.; Jiménez-Moreno, N.; Ancín-Azpilicueta, C. Stability of phenolic compounds in grape stem extracts. Antioxidants 2020, 9, 720. [Google Scholar] [CrossRef] [PubMed]
  44. Wu, S.; Shen, D.; Wang, R.; Li, Q.; Mo, R.; Zheng, Y.; Liu, Y. Phenolic profiles and antioxidant activities of free, esterified and bound phenolic compounds in walnut kernel. Food Chem. 2021, 350, 129217. [Google Scholar] [CrossRef] [PubMed]
  45. Halliwell, B. ¿Are polyphenols antioxidants or pro-oxidants? ¿What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys. 2008, 476, 107–112. [Google Scholar] [CrossRef] [PubMed]
  46. Kondakci, E.; Ozyurek, M.; Guclu, K.; Apak, R. Novel pro-oxidant activity assay for polyphenols, vitamins C and E using a modified CUPRAC method. Talanta 2013, 115, 583–589. [Google Scholar] [CrossRef]
  47. Zhao, J.; Wang, X.; Lin, H.; Lin, Z. Hazelnut and its by-products: A comprehensive review of nutrition, phytochemical profile, extraction, bioactivities and applications. Food Chem. 2023, 413, 135576. [Google Scholar] [CrossRef] [PubMed]
  48. Ono, E.; Waki, T.; Oikawa, D.; Murata, J.; Shiraishi, A.; Kato, M.; Ogata, N.; Takahashi, S.; Yamaguchi, M.; Horikawa, M.; et al. Glycoside-specific glycosyltransferases catalyze regio-selective sequential glucosylations for a sesame lignan, sesaminol triglucoside. TPJ Plant J. 2020, 101, 1221–1233. [Google Scholar] [CrossRef]
  49. Ahmed, S.A.; Sarma, P.; Barge, S.R.; Swargiary, D.; Devi, G.S.; Borah, J.C. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/FoxO1/AKT/GSK3β signaling cascade. Chem. Biol. Interact. 2023, 371, 110347. [Google Scholar] [CrossRef] [PubMed]
  50. Herrou, J.; Czyz, D.M.; Willett, J.W.; Kim, H.S.; Chhor, G.; Babnigg, G.; Kim, Y.; Crosson, S. WrpA is an atypical flavodoxin family protein under regulatory control of the Brucella abortus general stress response system. J. Bacteriol. 2016, 198, 1281–1293. [Google Scholar] [CrossRef]
  51. Ma, Z.; Du, B.; Li, J.; Yang, Y.; Zhu, F. An insight into anti-inflammatory activities and inflammation related diseases of anthocyanins: A review of both in vivo and in vitro investigations. Int. J. Mol. Sci. 2021, 22, 11076. [Google Scholar] [CrossRef]
  52. Lainas, K.; Alasalvar, C.; Bolling, B.W. Effects of roasting on proanthocyanidin contents of Turkish Tombul hazelnut and its skin. J. Funct. Foods. 2016, 23, 647–653. [Google Scholar] [CrossRef]
  53. Pham, E.C.; Van, L.V.; Nguyen, C.V.; Duong, N.T.N.; Le Thi, T.V.; Truong, T.N. Acute and sub-acute toxicity evaluation of Merremia tridentata (L.) stem extract on mice. Toxicon 2023, 227, 107093. [Google Scholar] [CrossRef] [PubMed]
  54. Asare, G.A.; Gyan, B.; Bugyei, K.; Adjei, S.; Mahama, R.; Addo, P.; Nyarko, L.; Wiredu, E.; Nyarko, A. Toxicity potentials of the nutraceutical Moringa oleifera at supra-supplementation levels. J. Ethnopharmacol. 2012, 139, 265–272. [Google Scholar] [CrossRef]
  55. Youns, M.; Hoheisel, J.D.; Efferth, T. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. Planta Med. 2010, 76, 2019–2025. [Google Scholar] [CrossRef] [PubMed]
  56. OECD. Test No. 423: Acute Oral toxicity—Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals, Section 4; OECD Publishing: Paris, France, 2002. [Google Scholar]
  57. Amanat, M.; Daula, A.; Singh, R. Acute toxicity assessment of methanolic extract of Zingiber roseum (Roscoe.) rhizome in swiss albino mice. Pharmacol. Res.-Mod. Chin. Med. 2023, 7, 100244. [Google Scholar] [CrossRef]
  58. Enciso, E.; Arroyo, J. Efecto antiinflamatorio y antioxidante de los flavonoides de las hojas de Jungia rugosa Less (matico de puna) en un modelo experimental en ratas. An. Fac. Med. 2011, 72, 231–237. [Google Scholar] [CrossRef]
  59. Joseph, S.G.; Carlos, P.M.; Elmer, L.C.; Alberto, S.G. Efecto antinociceptivo y antiinflamatorio de la metformina en modelos experimentales en ratón. Horiz. Med. 2019, 19, 49–57. [Google Scholar]
  60. Yera, A.O.; Cuevas, V.M.; Calzado, Y.R.; Guerra, Y.P.; Despaigne, S.J. Estudio comparativo de los efectos del D-004 y sustancias antiinflamatorias sobre la pleuresía inducida por carragenina en ratas. Rev. CENIC Cienc. Biológicas 2019, 50, 212–225. [Google Scholar]
  61. Annamalai, P.; Thangam, E.B. Vitex trifolia L. modulates inflammatory mediators via down-regulation of the NF-κB signaling pathway in carrageenan-induced acute inflammation in experimental rats. J. Ethnopharmacol. 2022, 298, 115583. [Google Scholar] [CrossRef]
  62. Serhan, C.N.; Chiang, N. Resolvins and Cysteinyl-containing Pro-Resolving Mediators Activate Resolution of Infectious Inflammation and Tissue Regeneration. Prostaglandins Other Lipid Mediat. 2023, 166, 106718. [Google Scholar] [CrossRef]
  63. Tan, B.L.; Norhaizan, M.E. Effect of high-fat diets on oxidative stress, cellular inflammatory response and cognitive function. Nutrients 2019, 11, 2579. [Google Scholar] [CrossRef] [PubMed]
  64. Truong, V.L.; Jeong, W.S. Antioxidant and anti-inflammatory roles of tea polyphenols in inflammatory bowel diseases. Food Sci. Hum. Wellness 2022, 11, 502–511. [Google Scholar] [CrossRef]
  65. Zhou, J.; Fang, C.; Rong, C.; Luo, T.; Liu, J.; Zhang, K. Reactive oxygen species-sensitive materials: A promising strategy for regulating inflammation and favoring tissue regeneration. Smart Mater. Med. 2023, 4, 427–446. [Google Scholar] [CrossRef]
  66. Li, K.K.; Shen, S.S.; Deng, X.; Shiu, H.T.; Siu, W.S.; Leung, P.C.; Hay Ko, C.; Cheng, B.H. Dihydrofisetin exerts its anti-inflammatory effects associated with suppressing ERK/p38 MAPK and Heme Oxygenase-1 activation in lipopolysaccharide-stimulated RAW 264.7 macrophages and carrageenan-induced mice paw edema. Int. Immunopharmacol. 2018, 54, 366–374. [Google Scholar] [CrossRef] [PubMed]
  67. Ghafoor, K.; Choi, Y.H.; Jeon, J.Y.; Jo, I.H. Optimization of ultrasound-assisted extraction of phenolic compounds, antioxidants, and anthocyanins from grape (Vitis vinifera) seeds. J. Agric. Food Chem. 2009, 57, 4988–4994. [Google Scholar] [CrossRef] [PubMed]
  68. Alrugaibah, M.; Washington, T.L.; Yagiz, Y.; Gu, L. Ultrasound-assisted extraction of phenolic acids, flavonols, and flavan-3-ols from muscadine grape skins and seeds using natural deep eutectic solvents and predictive modelling by artificial neural networking. Ultrason. Sonochem. 2021, 79, 3–12. [Google Scholar] [CrossRef]
  69. Borges-Martínez, E.; Gallardo-Velázquez, T.; Cardador-Martínez, A.; Moguel-Concha, D.; Osorio-Revilla, G.; Ruiz-Ruiz, J.C.; Martínez, C.J. Phenolic compounds profile and antioxidant activity of pea (Pisum sativum L.) and black bean (Phaseolus vulgaris L.) sprouts. Food Sci. Technol. 2021, 42, e46920. [Google Scholar] [CrossRef]
  70. Ortega-Medrano, R.J.; Ceja-Torres, L.F.; Vázquez-Sánchez, M.; Martínez-Ávila, G.C.G.; Medina-Medrano, J.R. Characterization of Cosmos sulphureus Cav. (Asteraceae): Phytochemical Screening, Antioxidant Activity and Chromatography Analysis. Plants. 2023, 12, 896. [Google Scholar] [CrossRef]
  71. Medina-Medrano, J.R.; Quiñones-Muñoz, T.A.; Arce-Ortíz, A.; Torruco-Uco, J.G.; Hernández-Martínez, R.; Lizardi-Jiménez, M.A.; Varela-Santos, E. Antioxidant activity of collagen extracts obtained from the skin and gills of Oreochromis sp. J. Med. Food 2019, 22, 722–728. [Google Scholar] [CrossRef]
  72. Ramos, L.Á.; Baez, D.A.; Ortiz, G.D.; Ruiz, J.C.R.; López, V.M.T. Antioxidant and antihypertensive activity of Gouda cheese at different stages of ripening. Food Chem. 2022, 10, 100284. [Google Scholar]
  73. Gutiérrez-Rebolledo, G.A.; Garduño-Siciliano, L.; García-Rodríguez, R.V.; Pérez-González, M.Z.; Chávez, M.I.; Bah, M.; Siordia-Reyes, G.A.; Jiménez-Arellanes, M.A. Anti-inflammatory and toxicological evaluation of Moussonia deppeana (Schldl. & Cham) Hanst and Verbascoside as a main active metabolite. J. Ethnopharmacol. 2016, 187, 269–280. [Google Scholar] [PubMed]
Molecules 29 03243 g001
Figure 1. Mass spectra (MS) of the aqueous extract of C. icaco seed.
Figure 1. Mass spectra (MS) of the aqueous extract of C. icaco seed.
Molecules 29 03243 g001
Table 1. Total content of phenolics, flavonoids, and condensed tannins, and antioxidant potential.
Table 1. Total content of phenolics, flavonoids, and condensed tannins, and antioxidant potential.
AssayContent
TPC 1124.14 ± 0.32
Flavonoids 21.65 ± 0.02
Condensed tannins 30.910 ± 0.01
Antioxidant techniquesIC50
DPPH 40.050
ABTS 40.074
FRAP 40.49
Data are shown as the mean (±), with its standard deviation (s.d.). 1 mg GAE/g of the extract; 2 mg EQ/g of the extract; 3 mg EC/g of the extract; 4 IC50, mg of extract/mL to inhibit 50% of the initial concentration of radicals, as well 50% of the reducing power. TPC, total phenolic content; IC50, median inhibitory concentration. Assays were carried out in triplicate (n = 3).
Table 2. Bioactive compounds identified in the Caco seed extract using flow injection–electrospray ionization analysis–Fourier transform cyclotron resonance spectrometry (FIA-ESI-FTICR-MS).
Table 2. Bioactive compounds identified in the Caco seed extract using flow injection–electrospray ionization analysis–Fourier transform cyclotron resonance spectrometry (FIA-ESI-FTICR-MS).
Theoretical m/zMeasured m/zFormula of the Element [M − H]+Error (ppm)CompoundRelative
Abundance
Positive mode
622.3596406622.35880C28H46O151.3502-acetyl-3-isobutanoyl-3,4-di (3-methylbutanoyl) sucrose3.055
Negative mode
756.0952107756.09669C36H36O181.956Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside (shisonin)1.01
170.0667055170.06637C8H10O4,1.9723,4-Dihydroxyphenylglycol1.080
856.1952003856.20052C38H48O226.213(+)-Sesaminol 2-O-beta-d-gentiotrioside2.014
758.3327712758.32797C39H42N4O126.331C8-beta-glucuronosyl-bilirubin-IX alpha1.56
328.9521572328.95623C10H12N5O6P12.381Deoxyadenosine monophosphate (dAMP)2.23
284.0726800284.07642C10H12N4O613.165Xanthosine1.40
84.0450460284.04698C5H8O23.0113-Methyl-2-butenal1.00
336.9370951336.94496C9H12N3O9P23.3425-hydroxy-CMP1.210
456.1216171456.13245C17H21N4O9P23.749Reduced flavodoxin1.516
Note: Error (ppm) was calculated as the absolute value.
Table 3. Frequency (%) of the appearance of behaviors of mice after a single intragastric administration of the AECS.
Table 3. Frequency (%) of the appearance of behaviors of mice after a single intragastric administration of the AECS.
Time (h)Behavioral ParametersExperimental Groups (g/kg)
Control0.512
1Piloerection0173333
Lethargy0000
Tachycardia0000
Hyperactivity0173317
2Piloerection0506783
Lethargy0000
Tachycardia017830
Hyperactivity00083
3Piloerection06710083
Lethargy0000
Tachycardia0010083
Hyperactivity00083
4Piloerection0173383
Lethargy0000
Tachycardia00017
Hyperactivity00170
5Piloerection0173350
Lethargy00050
Tachycardia00050
Hyperactivity0000
6Piloerection001750
Lethargy00050
Tachycardia00050
Hyperactivity0000
Data are shown as the mean (±), with its standard error of the mean (SEM); the values shown are percentage frequency values considering 6/6 to be 100%. AECS, aqueous extract of C. icaco seed (n = 6 per group).
Table 4. Effect of the Chrysobalanus icaco L. seed extract on the relative weight of vital organs in mice.
Table 4. Effect of the Chrysobalanus icaco L. seed extract on the relative weight of vital organs in mice.
Experimental Groups
(g/kg)		Organ–Body Weight Relationship (%)
LiverSpleenKidneys
Control5.33 ± 0.080.62 ± 0.031.32 ± 0.03
0.55.28 ± 0.240.66 ± 0.071.32 ± 0.11
14.75 ± 0.050.69 ± 0.061.21 ± 0.05
24.74 ± 0.130.60 ± 0.051.33 ± 0.04
Data are shown as the mean (±) with the standard error of the mean (SEM); percentages were calculated considering the net body weight on Day 14 of the study as 100%. ANOVA statistical analysis in of ranks and Student–Newman–Keuls (SNK) post hoc test (p < 0.05); (n = 6 per group).
Table 5. Effect of the aqueous extract of Chrysobalanus icaco L. seeds on the diameter (mm) of acute subplantar edema in mice.
Table 5. Effect of the aqueous extract of Chrysobalanus icaco L. seeds on the diameter (mm) of acute subplantar edema in mice.
Groups
(mg/kg)		Time (h)
1357
Carrageenan0.615 ± 0.020.751 ± 0.04 ●1.056 ± 0.04 ●▲0.791 ± 0.05 ●+
Indomethacin (10)0.417 ± 0.04 a
(32.30%)		0.285 ± 0.03 a●
(62.0%)		0.463 ± 0.03 a▲
(59.19%)		0.391 ± 0.04 a▲
(50.38%)
AECS (150)0.502 ± 002 a
(18.14%)		0.457 ± 0.02 ab
(39.14%)		0.499 ± 0.04 a
(52.76%)		0.434 ± 0.05 a
(45.21%)
AECS (300)0.413 ± 0.02 a
(32.89%)		0.409 ± 0.02 a
(45.50%)		0.542 ± 0.07 a▲
(48.68%)		0.431 ± 0.04 a+
(45.69%)
AECS (600)0.356 ± 0.02 ac
(42.15%)		0.376 ± 0.03 a
(49.88%)		0.445 ± 0.04 a
(57.85%)		0.359 ± 0.03 a
(54.64%)
Data are presented as the mean (±) and its standard error of the mean (SEM). Administration of the treatments was by the intragastric route 1 h prior to the injection of carrageenan. Values in parentheses indicate the percentage of inhibition on growth of the edema compared with the untreated carrageenan control group. Statistical analysis: ANOVA of bifactor repeated measures (RM) and the Student–Newman–Keuls (SNK) post hoc test (p ≤ 0.05). a Versus the carrageenan control; b vs. 10 mg/kg indomethacin; c vs. 150 mg/kg AECS; ● vs. 1 h, ▲ vs. 3 h, + vs. 5 h. AECS, aqueous extract of C. icaco seeds (n = 8 per group).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Arce-Ortiz, A.; Jiménez-Martínez, C.; Gutiérrez-Rebolledo, G.A.; Corzo-Ríos, L.J.; Olivo-Vidal, Z.E.; Mora-Escobedo, R.; Cruz-Narváez, Y.; Sánchez-Chino, X.M. Evaluation of the Antioxidant and Anti-Inflammatory Activities and Acute Toxicity of Caco Seed (Chrysobalanus icaco L.) in Murine Models. Molecules 2024, 29, 3243. https://doi.org/10.3390/molecules29143243

AMA Style

Arce-Ortiz A, Jiménez-Martínez C, Gutiérrez-Rebolledo GA, Corzo-Ríos LJ, Olivo-Vidal ZE, Mora-Escobedo R, Cruz-Narváez Y, Sánchez-Chino XM. Evaluation of the Antioxidant and Anti-Inflammatory Activities and Acute Toxicity of Caco Seed (Chrysobalanus icaco L.) in Murine Models. Molecules. 2024; 29(14):3243. https://doi.org/10.3390/molecules29143243

Chicago/Turabian Style

Arce-Ortiz, Abel, Cristian Jiménez-Martínez, Gabriel Alfonso Gutiérrez-Rebolledo, Luis Jorge Corzo-Ríos, Zendy Evelyn Olivo-Vidal, Rosalva Mora-Escobedo, Yair Cruz-Narváez, and Xariss M. Sánchez-Chino. 2024. "Evaluation of the Antioxidant and Anti-Inflammatory Activities and Acute Toxicity of Caco Seed (Chrysobalanus icaco L.) in Murine Models" Molecules 29, no. 14: 3243. https://doi.org/10.3390/molecules29143243

APA Style

Arce-Ortiz, A., Jiménez-Martínez, C., Gutiérrez-Rebolledo, G. A., Corzo-Ríos, L. J., Olivo-Vidal, Z. E., Mora-Escobedo, R., Cruz-Narváez, Y., & Sánchez-Chino, X. M. (2024). Evaluation of the Antioxidant and Anti-Inflammatory Activities and Acute Toxicity of Caco Seed (Chrysobalanus icaco L.) in Murine Models. Molecules, 29(14), 3243. https://doi.org/10.3390/molecules29143243

Article Metrics

Back to TopTop